InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Schorno Dean L, 首席财务官. Officer active across 1 company, notably RIGEL PHARMACEUTICALS INC. Cumulatively, 16 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €55k. Activity tracked since 24 January 2022. The latest transaction was filed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Schorno Dean L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
928 股@ US$47.50Common StockSEC:0000905148-26-004080:0
694 股@ US$12.70Common StockSEC:0000905148-26-004080:1
620 股@ US$18.70Common StockSEC:0000905148-26-004080:2
2,000 股@ US$24.20Common StockSEC:0000905148-26-004080:3
1,286 股@ US$24.20Common StockSEC:0000905148-26-004080:4
20,636 股0Common StockSEC:0000905148-26-000952:0
3,546 股@ US$34.6228.7% 占其流量Common StockSEC:0000905148-26-000678:0
5,488 股@ US$36.0146.5% 占其流量Common StockSEC:0000905148-26-000497:0
1,987 股@ US$20.0038.1% 占其流量Common StockSEC:0000905148-25-004492:0
2,036 股@ US$20.92174.7% 占其流量Common StockSEC:0000905148-25-000413:0
19,717 股0Common StockSEC:0000905148-25-000300:0
5,601 股@ US$1.129610.5% 占其流量Common StockSEC:0000905148-24-000446:0
209,000 股0Common StockSEC:0000905148-24-000306:0
5,389 股@ US$1.660114.7% 占其流量Common StockSEC:0001140361-23-004732:0
63,000 股0Common StockSEC:0001140361-23-003441:0
50,000 股0Common StockSEC:0001567619-22-001782:0
16 条申报中的 16 条
About Schorno Dean L
Schorno Dean L is Directeur Financier and EVP & Chief Financial Officer at RIGEL PHARMACEUTICALS INC. He has 11 filings in total, and across the 11 sampled filings, the sell amount is EUR 55186, with activity ranging from 2022-01-26 to 2026-02-19; the modal transaction nature is Attribution.
